Cuba’s Vaccine Could End up Saving Millions of Lives
Thanks to its public biotech sector and its government’s deep commitment to public health, Cuba is now the only low-income country to have made its own COVID vaccine. It’s already helped millions of Cubans, and it’s poised to help millions more around the world.

A medical worker displays a dose of Cuba’s Soberana 2 vaccine against COVID-19 at a school in Havana, Cuba. (Joaquin Hernandez / Xinhua via Getty Images)
Much of the press coverage of Cuba last week focused on the anti-government protests that didn’t eventuate. Less covered has been something of potentially greater global significance: its vaccination drive.
After a dire twelve months, when a too hasty reopening sent the pandemic surging, deaths peaking, and the country back into a crippling shutdown, a successful vaccination program has turned the pandemic around in the country. Cuba is now one of the few lower-income countries to have not only vaccinated a majority of its population, but the only one to have done so with a vaccine it developed on its own.
The saga suggests a path forward for the developing world as it continues struggling with the pandemic in the face of ongoing corporate-driven vaccine apartheid, and points more broadly to what’s possible when medical science is decoupled from private profit.